Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  1992-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0091-6749(92)90099-NPMID 1430701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man

  2004cited by this paper
• Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover

  2004cited by this paper
• Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates.

  1991cited by this paper
• Secretion of granule proteins from eosinophils and neutrophils is increased in asthma.

  1991cited by this paper
• Effect of steroids on immunoglobulin-induced eosinophil degranulation.

  1991cited by this paper
• The role of the eosinophil in asthma.

  1991cited by this paper
• Airways inflammation in nocturnal asthma.

  1991cited by this paper
• Bone turnover during high dose inhaled corticosteroid treatment.

  1991cited by this paper
• Plasma histamine, epinephrine, cortisol, and leukocyte β‐adrenergic receptors in nocturnal asthma

  1991cited by this paper
• Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia.

  1991cited by this paper
• Airway luminal liquid. Sources and role as an amplifier of bronchoconstriction.

  1991cited by this paper
• Adrenaline and nocturnal asthma.

  1990cited by this paper
• Formoterol in the treatment of nocturnal asthma.

  1990cited by this paper
• Use of inhaled corticosteroids in patients with mild asthma.

  1990cited by this paper
• Factors related to the nocturnal worsening of asthma.

  1990cited by this paper
• Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season.

  1990cited by this paper
• Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide.

  1990cited by this paper
• Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline.

  1990cited by this paper
• Eosinophilic inflammation in asthma.

  1990cited by this paper
• Beta 2-adrenergic receptors on eosinophils. Binding and functional studies.

  1990cited by this paper
• The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors

  1990cited by this paper
• The eosinophil and bronchial asthma: current understanding.

  1990cited by this paper
• Beta2-Adrenergic Receptors on Eosinophils: Binding and Functional Studies

  1990cited by this paper
• Nocturnal asthma: effect of treatment with oral sustained-release terbutaline, inhaled budesonide, and the two in combination.

  1989cited by this paper
• Circadian change in bronchial responsiveness and airflow obstruction in asthmatic children.

  1989cited by this paper
• The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge.

  1989cited by this paper
• Bioequivalent doses of budesonide and prednisone in moderate and severe asthma.

  1989cited by this paper
• Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity.

  1988cited by this paper
• Dosage and time effects of inhaled budesonide on bronchial hyperreactivity.

  1988cited by this paper
• Epidemiology of nocturnal asthma.

  1988cited by this paper
• Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis.

  1988cited by this paper
• Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication.

  1988cited by this paper
• The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs.

  1988cited by this paper
• Nocturnal events related to "morning dipping" in bronchial asthma.

  1988cited by this paper
• Inflammatory mechanisms and nocturnal asthma.

  1988cited by this paper
• Peripheral blood eosinophil counts and bronchial responsiveness.

  1987cited by this paper
• Heat-labile neutrophil chemotactic activity in subjects with asthma after allergen inhalation: relation to the late asthmatic reaction and effects of asthma medication.

  1987cited by this paper
• Generation and partial characterization of eosinophil chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic response.

  1986cited by this paper
• Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

  1985cited by this paper
• Direct interaction of guinea pig eosinophils and adrenergic agents.

  1985cited by this paper
• Standardized lung function testing.

  1984cited by this paper
• Standardized lung function testing. Report working party.

  1983cited by this paper
• Neutrophil chemotactic activity in antigen-induced late asthmatic reactions.

  1982cited by this paper
• The eosinophil and the lung.

  1982cited by this paper
• Glucocorticoid receptors in normal human eosinophils: comparison with neutrophils.

  1981cited by this paper
• Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels.

  1980cited by this paper
• Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol.

  1980cited by this paper
• Blood eosinophil leucocyte and eosinophil cationic protein. In vivo study of the influence of beta-2-adrenergic drugs and steroid medication.

  1978cited by this paper
• Variations of Blood Eosinophils and Eosinophil Cationic Protein in Serum in Patients with Bronchial Asthma

  1978cited by this paper
• Antigen-induced neutrophil chemotactic activity in man. Correlation with bronchospasm and inhibition by disodium cromoglycate.

  1978cited by this paper
• Radioimmunoassay of Human Eosinophil Cationic Protein

  1977cited by this paper
• Bronchial reactivity to inhaled histamine: a method and clinical survey

  1977cited by this paper
• Twenty-four-hour rhythm in the bronchial hyperreactivity to house dust in asthmatics.

  1977cited by this paper
• Total eosinophil counts in the management of bronchial asthma.

  1975cited by this paper
• Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients.

  1962cited by this paper

• Oxcarbazepine-Induced Cutaneous Reaction in a Female of Mexican Ancestry

  2019cites this paper
• Periostin - A biomarker in adults with asthma

  2019cites this paper
• The Clinical Relevance of Periostin in Asthma

  2018cites this paper
• Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthma

  2017cites this paper
• Serum periostin: Population reference range and daily variation

  2015cites this paper
• Psychological stress and aging: role of glucocorticoids (GCs)

  2011cites this paper
• Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.

  2010cites this paper
• Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.

  2010cites this paper
• Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.

  2009cites this paper
• Inflammatory markers in and the treatment of acute pre-school viral wheeze

  2007cites this paper
• The treatment of asthma in children: inhaled corticosteroids.

  2007cites this paper
• Chronopharmacology and controlled drug release

  2005cites this paper
• Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.

  2005cites this paper
• Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

  2005cites this paper
• Evaluation of montelukast in 8 to 14 year old children with mild persistent asthma and compared with inhaled corticosteroids.

  2004cites this paper
• Impact of Age and Administration Regimens on the Suppressive Effect of Inhaled Glucocorticoids on Eosinophil Markers in Children with Asthma

  2004cites this paper
• Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.

  2004cites this paper
• Cellular and immunological markers of allergic and intrinsic bronchial asthma

  2004cites this paper
• Absence of association of peripheral blood eosinophilia or increased eosinophil cationic protein with bronchial hyperresponsiveness during asthma remission.

  2003cites this paper
• Ratio of serum eosinophil cationic protein/blood eosinophil counts in children with asthma: comparison between acute exacerbation and clinical remission.

  2003cites this paper
• Circadian variations in serum eosinophil cationic protein, and serum and urine eosinophil protein X

  2003cites this paper
• Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma

  2003cites this paper
• Circadian Variation of Exhaled Nitric Oxide and Urinary Eosinophil Protein X in Asthmatic and Healthy Children

  2002cites this paper
• Budesonide for chronic asthma in children and adults.

  2001cites this paper
• Sampling methods: urine/blood analysis.

  2000cites this paper
• Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).

  2000cites this paper
• Eosinophil Activation Markers in Induced Sputum in Asthmatics

  2000cites this paper
• Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.

  2000cites this paper
• Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.

  2000cites this paper
• Budesonide Inhalation Suspension

  2000cites this paper
• Circadian variation of urinary eosinophil protein X in asthmatic and healthy children

  1999cites this paper
• Biologic rhythms in the immune system.

  1999cites this paper
• Budesonide versus placebo for chronic asthma in children and adults

  1999cites this paper
• An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma.

  1999cites this paper
• Nitric oxide metabolites in patients with asthma: induced sputum versus blood.

  1999cites this paper
• Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.

  1999cites this paper
• Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.

  1999cites this paper
• Efficacy and safety of inhaled corticosteroids. New developments.

  1998cites this paper
• Eosinophil and mast cell parameters in children with stable moderate asthma

  1998cites this paper
• Anti-inflammatory actions of glucocorticoids: molecular mechanisms.

  1998cites this paper
• Peripheral blood markers: evaluation of inflammation in asthma.

  1998cites this paper
• Correlation among urinary eosinophil protein X, leukotriene E4, and 11‐dehydrothromboxane B2 in patients with spontaneous asthmatic attack

  1998cites this paper
• The pathogenesis of nocturnal asthma in childhood

  1998cites this paper
• Montelukast for Chronic Asthma in 6- to 14-Year-Old Children A Randomized, Double-blind Trial

  1998cites this paper
• 気管支喘息患者におけるスポット尿中Eosinophil Protein X測定の意義に関する基礎的検討

  1998cites this paper
• Eosinophils and pulmonary function: an epidemiologic study of adolescents and young adults.

  1998cites this paper
• Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy.

  1997cites this paper
• Serum eosinophil cationic protein levels and bronchodilator responses at acute asthma exacerbation.

  1997cites this paper
• CHRONOBIOLOGY AND CHRONOPATHOPHYSIOLOGY OF NOCTURNAL ASTHMA

  1997cites this paper
• The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma.

  1997cites this paper
• Steroid therapy in obstructive airway diseases

  1997cites this paper
• Molecular mechanisms of glucocorticoid action in asthma.

  1997cites this paper
• Comparison of sputum and serum eosinophil cationic protein (ECP) levels in nonatopic asthma and chronic obstructive pulmonary disease.

  1997cites this paper
• Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthmi

  1996cites this paper
• Epidemiology and exogenous factors in nocturnal airflow limitation in children

  1996cites this paper
• Clinical Pharmacokinetics of Bambuterol

  1996cites this paper
• Proteína catiónica del eosinófilo en el asma infantil. Correlación con la clínica y función pulmonar

  1996cites this paper
• Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma.

  1995cites this paper
• Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma

  1995cites this paper
• Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma.

  1995cites this paper
• Inflammatory cell number and mediators in bronchoalveolar lavage fluid and peripheral blood in subjects with asthma with increased nocturnal airways narrowing.

  1995cites this paper
• The role of airway inflammation in the pathophysiology of nocturnal asthma noeturnal asthma

  1995cites this paper
• Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma.

  1995cites this paper
• Anti‐inflammatory effects of long‐acting β‐agonists in asthma

  1995cites this paper
• Adverse effects of eosinophilia and smoking on the natural history of newly diagnosed chronic bronchitis.

  1995cites this paper
• Glucocorticoid resistance in asthma.

  1995cites this paper
• Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population

  1994cites this paper
• Nocturnal asthma: not a separate disease entity.

  1994cites this paper
• Changes in serum ECP levels after storage at room temperature

  1994cites this paper
• Inflammation in nocturnal asthma?

  1994cites this paper
• Eosinophil inflammation in asthma.

  1994cites this paper
• Indirect airways responsiveness and cell activation as inflammatory parameters in nocturnal asthma

  1994cites this paper
• Topical Review Nocturnal asthma: not a separate disease entity

  1994cites this paper
• Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

  1993cites this paper
• Efficacy and Safety of Inhaled Corticosteroids in Asthma

  1993cites this paper